Periodontal and peri-implant diseases arise from microbial dysbiosis and immune dysregulation, perpetuating chronic inflammation and tissue destruction.
Current treatments often target either the microbiome or immune response, failing to address both simultaneously for long-term resolution.
Our research focuses on developing therapeutic interventions that restore microbial balance and shift immune responses toward pro-resolution, promoting sustainable oral health outcomes.